Two Pet Stocks to Track As the Industry Continues to Grow

NXTP Stock
NXTP Stock

The novel coronavirus pandemic was a stimulus for the ever-evolving pet industry. Pet adoption grew significantly as millions of Americans were forced to stay home. All this compels investors to find the right pet stocks to buy.

At least 67% of American households are animal owners, according to the American Pet Products Association. This number had risen by 11 percent since the survey started in 1988. The ProShares Pet Care ETF has also gained by an incredible 30 percent contrast with the S&P 500, which has only risen by 4 percent over the current year.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Pet food sales tend to improve the bottom lines of businesses relative to other pet things. Therefore, businesses look at online platforms to build a strategic advantage over their competition. Furthermore, wealthy pet owners, particularly millennials, pay extra for pet products like organic food.

With lockout controls in effect, Chewy is creating some huge waves. Chewy’s website is an all-in-one place to buy animal feed, toys, and other items. That’s maybe why CHWY’s 6-month return on stock is 87%. In the first quarter, sales rose 46 per cent, their biggest rise since it was made public. It narrowed its adjusted share loss to 12 cents that was 50 percent smaller than Wall Street estimates. The company’s main revenue catalyst was a 33% rise in active customers. However, revenue per active consumer rose by 6.6%.

The Autoship, which allows customers to refill their pets’ supplies at some times, is one of the unique propositions of Chewy. This currently constitutes approximately 70% of the company’s revenue mix. It will take few years to reach profitability but the Chewy stock is currently an excellent investment.

Among animal drugs and diagnosis, Zoetis became the best of the best. That is why it is one of today’s greatest pet stocks. The total return of ZTS shares for 6 months is 15%. Revenue for the second quarter was 1.5 billion, higher than Wall Street’s estimate of 1.36 billion. Net income was 377 million, up slightly from 371 million in the previous period. In addition, the company spun off by Pfizer (NYSE:PFE) in 2013, updated its 2020 sales forecast to range between $6.30 billion and $6.47 billion from its earlier forecast in the range of $5.95 billion to $6.25 billion.

The business has spent extensively in a competitive sector in animal diagnostics valued over $4 billion. With its latest purchase of ZNLabs and Ethos Diagnostic Technology, it has significantly accelerated its M&A transactions. The ability to capture a growing industry and also a strong management team makes ZTS an attractive stock to track.


Please enter your comment!
Please enter your name here